Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medartis Holding AGXSWX:MED +1.84%84 EV-to-OCF is 35.18 as of Jul. 29, 2026, which is 21% below its 10-year median of 44.65. GuruFocus rates XSWX:MED with a GF Score™ of 84/100 and a GF Value™ of CHF108.03 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 86.74% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Medartis Holding AG's Enterprise Value is CHF1,225.0 Mil.
Medartis Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF34.8 Mil. Therefore, Medartis Holding AG's EV-to-OCF for today is 35.18.
The historical rank and industry rank for Medartis Holding AG's EV-to-OCF or its related term are showing as below:
XSWX:MED'
s EV-to-OCF Range Over the Past 10 Years
Min: -287.28 Med: 44.65 Max: 117.27
Current: 34.4
During the past 12 years, the highest EV-to-OCF of Medartis Holding AG was 117.27. The lowest was -287.28. And the median was 44.65.
XSWX:MED's EV-to-OCF is ranked worse than 86.74% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.81
vs XSWX:MED: 34.40
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medartis Holding AG (XSWX:MED) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medartis Holding AG's PE Ratio (TTM) for today is calculated as:
Medartis Holding AG's share price for today is CHF88.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.670.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medartis Holding AG EV-to-OCF Related Terms
Medartis Holding AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medartis Holding AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's EV-to-OCF falls into.
Medartis Holding AG's current Enterprise Value is CHF1,225.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF34.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a EV-to-OCF of 35.18 as of Jul. 29, 2026. This is 21% below median its historical median of 44.65. According to the industry distribution chart, Medartis Holding AG ranks #739 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 86.7%.
Is Medartis Holding AG's EV-to-OCF too high?
Medartis Holding AG's current EV-to-OCF of 35.18 is 21% below median its 10-year median of 44.65. The Medical Devices & Instruments industry median EV-to-OCF is 7.81. Medartis Holding AG's value of 35.18 is 350.4% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #739 out of 852 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medartis Holding AG has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #739 out of 852 companies for EV-to-OCF. This places Medartis Holding AG in the lower half of its industry. The industry median EV-to-OCF is 7.81. Medartis Holding AG's value of 35.18 is 350.4% above this benchmark. While the company's 10-year median is 44.65 vs. the industry median of 7.81, Medartis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.81, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current EV-to-OCF of 35.18 is 350.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current EV-to-OCF is 35.18, which is 21% below median its own 10-year median of 44.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF108.03, compared to a current price of CHF88.40 — trading 18.2% below its estimated fair value. The current EV-to-OCF is 35.18, which is 21% below median its 10-year median of 44.65 and 350.4% above the Medical Devices & Instruments industry median of 7.81. Medartis Holding AG's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current EV-to-OCF is 35.18 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF88.40 is trading 18.2% below its estimated GF Value™ of CHF108.03.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
EV-to-OCF: 35.18 (21% below median its 10-year median of 44.65)
GF Value™: CHF108.03 vs. price of CHF88.40 (18.2% below fair value)
Industry Position: 350.4% above the Medical Devices & Instruments median (#739 of 852)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
84GF Score
Get the complete analysis for XSWX:MED
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
